Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
16 December 2017 |
Main ID: |
NCT03223233 |
Date of registration:
|
17/07/2017 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Predicting the Severity of Post-cesarean Wound Infections Using Serum Procalcitonin Levels
|
Scientific title:
|
Predicting the Severity of Post-cesarean Wound Infections Using Serum Procalcitonin Levels |
Date of first enrolment:
|
May 2, 2017 |
Target sample size:
|
90 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT03223233 |
Study type:
|
Observational [Patient Registry] |
Study design:
|
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Turkey
| | | | | | | |
Contacts
|
Name:
|
Alev Atis, MD,ObGyn |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Kanuni Sultan Suleyman Training and Research Hospital |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- who developed surgical site infection after their cesarean sections.
- 18-40 years old
Exclusion Criteria:
- history of chorioamnionitis and premature rupture of membranes
- urinary tract infections
- any infectious condition other than surgical site infection
Age minimum:
18 Years
Age maximum:
40 Years
Gender:
Female
|
Health Condition(s) or Problem(s) studied
|
Cesarean Wound Disruption
|
Wound Infection
|
Intervention(s)
|
Other: procalcitonin level
|
Primary Outcome(s)
|
Serum procalcitonin levels in participants who developed wound infection after cesarean sections
[Time Frame: 5 months]
|
Secondary ID(s)
|
2016/12.2
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|